ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

IGXT IntelGenx Technologies Corporation (QB)

0.1619
-0.0166 (-9.30%)
May 03 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 136,907
Bid Price 0.1505
Ask Price 0.179
News -
Day High 0.179935

Low
0.09

52 Week Range

High
0.223725

Day Low 0.15884
Company Name Stock Ticker Symbol Market Type
IntelGenx Technologies Corporation (QB) IGXT OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0166 -9.30% 0.1619 15:59:57
Open Price Low Price High Price Close Price Prev Close
0.178 0.15884 0.179935 0.1785
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
31 136,907 $ 0.176219 $ 24,126 - 0.09 - 0.223725
Last Trade Time Type Quantity Stock Price Currency
15:59:57 100 $ 0.1619 USD

IntelGenx Technologies Corporation (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
41.92M 174.66M 124.54M 1.04M -9.93M -0.06 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

IntelGenx Technologies (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No IGXT Message Board. Create One! See More Posts on IGXT Message Board See More Message Board Posts

Historical IGXT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.16750.180.146440.1656615178,971-0.0056-3.34%
1 Month0.190.190.139550.1678732130,313-0.0281-14.79%
3 Months0.13630.190.1310.1654507101,5890.025618.78%
6 Months0.150.1990.1020.154100697,7260.01197.93%
1 Year0.14610.2237250.090.153588589,6810.015810.81%
3 Years0.6680.71040.090.3059483136,333-0.5061-75.76%
5 Years0.560.71040.090.311859199,215-0.3981-71.09%

IntelGenx Technologies (QB) Description

IntelGenx Corp. is a drug delivery company established in 2003 and headquartered in Montreal, Quebec, Canada. Our focus is on the development and manufacturing of novel oral thin film products for the pharmaceutical market. More recently, we have made the strategic decision to enter the Canadian cannabis market with a non-prescription cannabis infused oral film expected to be launched in 2021 and in 2020 we made the decision to enter the psychedelic market. In addition, we are offering partners a comprehensive portfolio of pharmaceutical services, including pharmaceutical research and development ("R&D"), clinical monitoring, regulatory support, tech transfer, manufacturing scale-up and commercial manufacturing. IntelGenx Corp. is the directly and indirectly fully owned Canadian operating company of IntelGenx Technologies Corp. The US parent IntelGenx Technologies Corp. is listed on the TSX and OTC-QB. For more information, visit www.intelgenx.com

Your Recent History

Delayed Upgrade Clock